| |
Earlier HCV Treatment Reduces Serious Liver Disease Outcomes
|
| |
| |
Reported by Jules Levin
AASLD 2013
Again in light of the recommendations to treat or prioritize treatment for those with advanced HCV disease
this study's objective is-
To evaluate the potential long-term impact on liver disease
complications associated with treating HCV patients before they
progress to cirrhosis
and CONCLUDED-
"· The watchful waiting approach to the treatment of
HCV genotype 1 could lead to substantially more
cases of advanced liver disease.
-- Treating at earlier stages of liver disease is
associated with higher SVR rates.
· Earlier treatment with more effective therapies
like SOF could curb future liver disease and the
downstream costs associated with advancing
disease."
"Cases of liver disease complications were more than tripled in the cohort of patients with compensated cirrhosis than in the cohort without
cirrhosis (Figure 3)."
from Jules: so its actually less costly in the long term ti treat earlier, suggests this study.
Treating HCV Earlier vs at Cirrhosis Reduces Serious Liver Disease Outcomes - (08/08/14)
|
|
| |
| |
|
|
|
